Financials
Financial year 2025
Dr. Van der Heyden Jan from Knokke-Heist, company number BE0724839428, closed financial year 2025 with a result of € 680,239 after tax. For that financial year Dr. Van der Heyden Jan recorded a gross margin of € 939,781 and equity of € 18,550. Compared with financial year 2024, the result moved from € 558,077 to € 680,239. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 30, 2026.
€ 18,550
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 680,239
▲ 22% vs 2024
Profit after tax over the fiscal year.
€ 359,025
▲ 44% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 680,239 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 48,049
▼ 40% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 48,376
▼ 41% vs 2024
€ 32,025 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 7,824
▲ 130% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,075
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 858,174 | € 818,932 | € 797,451 | € 939,781 | ▲ 18% |
| Profit after taxes | € 627,377 | € 584,236 | € 558,077 | € 680,239 | ▲ 22% |
| Equity | € 20,400 | € 18,550 | € 18,550 | € 18,550 | |
| Total debts | € 952,452 | € 705,266 | € 644,093 | € 739,514 | ▲ 15% |
| Cash | € 468,494 | € 132,225 | € 249,385 | € 359,025 | ▲ 44% |
| Retained profit | € 1,850 | € 0 | € 0 | € 0 | |
| Dividend | € 1,558,503 | € 586,086 | € 558,077 | € 680,239 | ▲ 22% |
| Bank debt | € 139,716 | € 109,802 | € 82,612 | € 48,376 | ▼ 41% |
| Balance sheet total | € 972,852 | € 723,816 | € 662,643 | € 758,064 | ▲ 14% |
Key figures of Dr. Van der Heyden Jan, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Van der Heyden Jan?
What happened at Dr. Van der Heyden Jan in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 680,239 (▲ 22% vs 2024). Source: NBB ↗
- New establishment in Knokke-Heist. KBO
- Start of the company according to the CBE. KBO
- Jan Van der Heyden became a director. NBB
- Vanessa Schelfhout became a director. NBB
In short
From € 627,377 profit in 2022 to € 680,239 profit in 2025.
Paid € 800,377 in corporate taxes since 2022.
Best year ever: 2025, with € 680,239 profit.
Paid out € 3.4 million in dividends to the owners in total.
Management
Behind Dr. Van der Heyden Jan are Jan Van der Heyden and Vanessa Schelfhout. The same people are also behind Rayos Medicinal. Jan Van der Heyden is also behind CATHLAB.
Directors
According to the 2025 annual accounts
since 2019
since 2019
Establishments
Establishment units
Physical locations of this company
Asterstraat 17
8300 Knokke-Heist
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0724.839.428
- VAT number
- BE 0724.839.428
- Registered office
- Asterstraat 17, 8300 Knokke-Heist
- Names & denominations
- Dr. Van der Heyden Jan
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 April 2019
- Peppol
- Active · Active since 20 Mar 2025